• SENSEX
    NIFTY 50
Healthcare

DCGI orders suspension of Serum's India trials of AstraZeneca's COVID-19 vaccine

Updated : September 12, 2020 08:25 AM IST

Drug regulator has asked Serum Institute of India to suspend recruitment in its clinical trials of AstraZeneca Plc's potential COVID-19 vaccine in the country until further orders, Reuters partner ANI reported on Friday.
DCGI orders suspension of Serum's India trials of AstraZeneca's COVID-19 vaccine

You May Also Like

Live TV
Advertisement